SABS vs. IVVD
SABS (SAB Biotherapeutics, Inc.) and IVVD (Invivyd Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, SABS returned -28.43%/yr vs -9.52%/yr for IVVD. At a 0.13 correlation, their price movements are largely independent.
Performance
SABS vs. IVVD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SABS achieves a -10.16% return, which is significantly higher than IVVD's -55.47% return.
SABS
- 1D
- -3.45%
- 1M
- -8.94%
- YTD
- -10.16%
- 6M
- -9.19%
- 1Y
- 80.65%
- 3Y*
- -28.43%
- 5Y*
- -49.13%
- 10Y*
- —
IVVD
- 1D
- -3.51%
- 1M
- -25.17%
- YTD
- -55.47%
- 6M
- -50.67%
- 1Y
- 13.84%
- 3Y*
- -9.52%
- 5Y*
- —
- 10Y*
- —
SABS vs. IVVD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
SABS SAB Biotherapeutics, Inc. | -10.16% | -1.43% | -44.81% | 16.55% | -92.45% | -21.19% |
IVVD Invivyd Inc. | -55.47% | 457.44% | -88.75% | 162.67% | -79.34% | -65.23% |
Correlation
The correlation between SABS and IVVD is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Aug 9, 2021 | 0.13 |
Fundamentals
SABS:
$179.96M
IVVD:
$340.64M
SABS:
-$0.01
IVVD:
-$0.40
SABS:
0.79
IVVD:
1.68
SABS:
$0.00
IVVD:
$55.87M
SABS:
-$2.35M
IVVD:
$51.92M
SABS:
$994.59K
IVVD:
-$79.85M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SABS vs. IVVD — Risk / Return Rank
SABS
IVVD
SABS vs. IVVD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SAB Biotherapeutics, Inc. (SABS) and Invivyd Inc. (IVVD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SABS | IVVD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.87 | ||
| Sortino ratioReturn per unit of downside risk | +0.51 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.15 | +0.08 |
| Calmar ratioReturn relative to maximum drawdown | 2.40 | 0.22 | +2.18 |
| Martin ratioReturn relative to average drawdown | 5.41 | 0.42 | +4.98 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SABS | IVVD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.97 | 0.10 | +0.87 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.44 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.44 | -0.26 | -0.18 |
Drawdowns
SABS vs. IVVD - Drawdown Comparison
The maximum SABS drawdown since its inception was -99.01%, roughly equal to the maximum IVVD drawdown of -99.36%. Use the drawdown chart below to compare losses from any high point for SABS and IVVD.
Loading charts...
Drawdown Indicators
| SABS | IVVD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.01% | -99.36% | +0.35% |
Max Drawdown (1Y)Largest decline over 1 year | -33.80% | -63.89% | +30.09% |
Max Drawdown (3Y)Largest decline over 3 years | -88.96% | -92.90% | +3.94% |
Max Drawdown (5Y)Largest decline over 5 years | -99.01% | — | — |
Current DrawdownCurrent decline from peak | -97.01% | -98.04% | +1.03% |
Average DrawdownAverage peak-to-trough decline | -78.03% | -91.13% | +13.10% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.97% | 32.71% | -17.74% |
Volatility
SABS vs. IVVD - Volatility Comparison
The current volatility for SAB Biotherapeutics, Inc. (SABS) is 20.36%, while Invivyd Inc. (IVVD) has a volatility of 30.40%. This indicates that SABS experiences smaller price fluctuations and is considered to be less risky than IVVD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SABS | IVVD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.36% | 30.40% | -10.04% |
Volatility (6M)Calculated over the trailing 6-month period | 44.46% | 68.69% | -24.23% |
Volatility (1Y)Calculated over the trailing 1-year period | 83.77% | 140.21% | -56.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 111.97% | 179.10% | -67.13% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 108.63% | 179.10% | -70.47% |
Dividends
SABS vs. IVVD - Dividend Comparison
Neither SABS nor IVVD has paid dividends to shareholders.
Financials
SABS vs. IVVD - Financials Comparison
This section allows you to compare key financial metrics between SAB Biotherapeutics, Inc. and Invivyd Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SABS and IVVD have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IVVD has higher volatility (30.40%) compared to SABS (20.36%). In terms of maximum drawdown, SABS dropped -99.01% vs IVVD's -99.36%.
SABS currently has the higher Sharpe Ratio (0.97 vs 0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SABS and IVVD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer